Onyx Scientific has been award a contract from Cancer Research UK to develop the chemistry and perform the GMP synthesis of an API for use in a Phase I trial. The technical team at Onyx Scientific was able to improve the synthetic methodology as well as provide an alternative route for the API, which will potentially help make the project more efficient and cost effective in the long term. Dr. Nigel Westwood, drug supply manager at Cancer Research UK, said, “Having had a very positive experie...